Press Releases VolitionRx Limited

Equities

VNRX

US9286611077

Market Closed - Nyse Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
0.9137 ^USD	+2.65%		+48.33%	+27.43%

Apr. 26	VolitionRx Limited Announces Board Changes	CI
Apr. 23	VolitionRx Limited Launches In-Clinic in U.S. and Europe Through Antech	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

VolitionRX: Q3 Earnings Snapshot	Nov. 15	AQ
Volition and VPG Launch Nu.Q Vet Cancer Test in UK and Ireland	Nov. 07	AQ
VolitionRx Limited Announces Second Quarter 2023 Financial Results and Business Update	23-08-15	AQ
VolitionRX: Q2 Earnings Snapshot	23-08-14	AQ
VolitionRx Limited Schedules Second Quarter 2023 Earnings Conference Call and Business Update	23-08-10	AQ
VolitionRx : Corporate Presentation May 2023	23-05-17	PU
VolitionRX: Q1 Earnings Snapshot	23-05-11	AQ
VolitionRx : Corporate Presentation May 2023	23-05-11	PU
VOLITIONRX LTD : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-05-10	AQ
VolitionRx : Corporate Presentation April 2023	23-04-25	PU
VolitionRx : Corporate Presentation March 2023	23-04-25	PU
VOLITIONRX LTD MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-03-15	AQ
VolitionRx Limited Schedules Full Year 2022 Earnings Conference Call and Business Update	23-03-13	AQ
VolitionRx Limited to Webcast Live at VirtualInvestorConferences.com March 9th	23-03-06	AQ
VOLITIONRX LTD : Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits (form 8-K)	23-02-21	AQ
VolitionRx Limited Announces Pricing of $7.525 Million Underwritten Public Offering of Common Stock	23-02-20	AQ
Volition's Nu.Q Vet Cancer Test Now Available for Pre-Order at the Point-of-Care Through Heska Corporation	23-02-17	AQ
VolitionRx : Corporate Presentation February 2023	23-01-31	PU
Volition to Take Part in Nu.Q Vet Commercial Strategy Webinar	23-01-23	AQ
Volition Announces Expansion of Availability of the Nu.Q Vet Cancer Test Through IDEXX's Reference Laboratory Network	23-01-13	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases VolitionRx Limited

Equities

VNRX

US9286611077

Press Releases

Filters